• Viridian Therapeutics (NASDAQ:VRDN) Earns Buy Rating from Needham & Company LLC

    المصدر: Buzz FX / 13 نوفمبر 2024 08:56:17   America/New_York


    Viridian Therapeutics (NASDAQ:VRDN) Earns Buy Rating from Needham & Company LLC Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Viridian Therapeutics ( NASDAQ:VRDN - Get Free Report ) 's stock had its "buy" rating re
    Read more...
شارك على،